The concomitant use of lapatinib and paracetamol - the risk of interaction

Lapatinib is a tyrosine kinase inhibitor used for the treatment of breast cancer. Paracetamol is an analgesic commonly applied to patients with mild or moderate pain and fever. Cancer patients are polymedicated, which involves high risk of drug interactions during therapy. The aim of the study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Karbownik, Agnieszka, Szałek, Edyta, Sobańska, Katarzyna, Grabowski, Tomasz, Klupczynska, Agnieszka, Plewa, Szymon, Wolc, Anna, Magiera, Magdalena, Porażka, Joanna, Kokot, Zenon J., Grześkowiak, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153549/
https://www.ncbi.nlm.nih.gov/pubmed/29464465
http://dx.doi.org/10.1007/s10637-018-0573-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153549/
https://www.ncbi.nlm.nih.gov/pubmed/29464465
http://dx.doi.org/10.1007/s10637-018-0573-1

Ejemplares similares